Design and synthesis of a PSMA inhibitor-doxorubicin conjugate for targeted prostate cancer therapy

ChemMedChem. 2006 Mar;1(3):299-302. doi: 10.1002/cmdc.200500044.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Cell Line, Tumor
  • Doxorubicin / chemistry
  • Doxorubicin / therapeutic use*
  • Drug Design
  • Humans
  • Male
  • Prostate-Specific Antigen / chemistry*
  • Prostatic Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents
  • Doxorubicin
  • Prostate-Specific Antigen